Annual report pursuant to Section 13 and 15(d)

Stock Plans (Tables)

v3.20.4
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Stock-based Compensation Expense The stock-based compensation expense by type of award and by operating expense grouping are presented below:

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2020

 

 

2019

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

Restricted stock units

 

$

5,560

 

 

$

952

 

Restricted stock awards

 

 

181

 

 

 

350

 

Machine Box contingent common stock issuances

 

 

(37

)

 

 

1,255

 

Performance-based stock options

 

 

8,480

 

 

 

8,000

 

Stock options

 

 

4,767

 

 

 

9,610

 

Employee stock purchase plan

 

 

493

 

 

 

490

 

Common stock issued for services

 

 

95

 

 

 

-

 

Total

 

$

19,539

 

 

$

20,657

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

 

 

Sales and marketing

 

$

889

 

 

$

1,035

 

Research and development

 

 

1,046

 

 

 

2,549

 

General and administrative

 

 

17,604

 

 

 

17,073

 

 

 

$

19,539

 

 

$

20,657

 

 

Schedule of Restricted Stock Award Activity

The Company’s restricted stock award activity for the year ended December 31, 2020 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2019

 

 

22,813

 

 

$

7.50

 

Granted

 

 

6,903

 

 

$

4.47

 

Vested

 

 

(29,716

)

 

$

6.80

 

Unvested at December 31, 2020

 

 

-

 

 

 

 

 

 

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock units activity for the year ended December 31, 2020 was as follows:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2019

 

 

142,145

 

 

$

6.71

 

Granted

 

 

914,157

 

 

$

10.94

 

Forfeited

 

 

(26,250

)

 

$

8.44

 

Vested

 

 

(200,928

)

 

$

5.85

 

Unvested at December 31, 2020

 

 

829,124

 

 

$

11.53

 

 

 

Schedule of Stock Option Activity

The activity related to all other stock options for the year ended December 31, 2020 was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2019

 

 

5,196,778

 

 

$

13.09

 

 

 

 

 

 

 

Granted

 

 

768,000

 

 

$

7.01

 

 

 

 

 

 

 

Exercised

 

 

(163,359

)

 

$

5.70

 

 

 

 

 

 

 

Forfeited

 

 

(234,917

)

 

$

8.61

 

 

 

 

 

 

 

Expired

 

 

(166,432

)

 

$

14.44

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

5,400,070

 

 

$

12.60

 

 

6.88 years

 

$

85,632

 

Exercisable at December 31, 2020

 

 

4,187,251

 

 

$

13.91

 

 

6.34 years

 

$

60,870

 

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the years ended December 31, 2020 and 2019 are set forth in the table below:

 

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Expected term (in years)

 

0.5 - 2.0

 

 

0.5 - 2.0

 

Expected volatility

 

65% - 130%

 

 

62% - 71%

 

Risk-free interest rate

 

0.1% - 1.5%

 

 

1.7% - 2.5%

 

Expected dividend yield

 

 

 

 

 

 

 

2018 Performance Base Stock Incentive Plan [Member]  
Summary of Fair Value Assumptions of Performance Awards

The assumptions used in the Monte Carlo simulation model for computing the fair values of the Performance Options on the modification date and immediately before the modification are set forth in the table below:

 

Amendment date stock price

 

$

8.83

 

Expected volatility

 

 

80

%

Risk-free interest rate

 

 

0.6

%

Expected dividend yield

 

 

%

Cost of equity

 

 

12

%

 

 

Timebased Stock Option [Member]  
Schedule of Fair Value Assumptions The assumptions used in calculating the fair values of time-based stock options granted during the years ended December 31, 2020 and 2019 are set forth in the table below:

 

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Expected term (in years)

 

6.0 - 6.1

 

 

6.0 - 6.1

 

Expected volatility

 

68% - 83%

 

 

65% - 68%

 

Risk-free interest rate

 

0.4% - 1.2%

 

 

1.5% - 2.6%

 

Expected dividend yield

 

 

 

 

 

 

 

Performance-based Stock Options [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan The Company values Performance Options using a Monte Carlo simulation model. A fair value per share is determined for each of the three equal tranches of each Performance Option. The assumptions used in the Monte Carlo simulation model for computing the grant date fair values of the Performance Options granted during the year ended December 31, 2020 and 2019 are set forth in the table below:

 

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Grant date stock price

 

$

11.10

 

 

$4.65 - $8.34

 

Dividend yield

 

 

%

 

 

%

Risk-free interest rate

 

 

0.8

%

 

 

2.7

%

Estimated volatility

 

 

85

%

 

 

65

%

 

 

Schedule of Stock Option Activity

The activity related to Performance Options for the year ended December 31, 2020 was as follows:

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

 

Value

 

Outstanding at December 31, 2019

 

 

4,484,739

 

 

$

16.68

 

 

 

 

 

 

 

 

 

Granted

 

 

120,000

 

 

$

11.10

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(370,719

)

 

$

5.62

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

4,234,020

 

 

$

10.55

 

 

7.55 years

 

 

$

 

Exercisable at December 31, 2020

 

 

 

 

$

 

 

 

 

 

$